DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

01066 WEIGAO GROUP

Trading Add to Porfolio
Index Constituent : HS Composite Index, HS Comp. L & M Index, HS Comp. MidCap Ind, HS Comp. M & S Index, Stock Connect HK Ind, Stock Connect HK MS
Major Shareholders Chen Xueli & Associates (46.03%) Sector Health Care & Biotechnology
Web Site http://www.weigaogroup.com Tel (86 631) 5621-999
Email wggf@weigaogroup.com Fax (86 631) 5621-999
Related Equities N/A
Principal Activities The Group is principally engaged in the research and development, production and sale of medical device products, orthopaedic products, interventional products, pharma packaging products, blood management products, and operates financing business.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
威高集团有限公司 2,159,755,676(L)  47.76(L)  07/08/2018
陈学利 2,159,755,676(L)  47.76(L)  07/08/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
周淑华 15,300,000(L)  0.34(L)  07/08/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top